These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19440711)

  • 1. The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?
    Valenti L; Fracanzani AL; Fargion S
    Semin Immunopathol; 2009 Sep; 31(3):359-69. PubMed ID: 19440711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
    Roh YS; Seki E
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):38-42. PubMed ID: 23855294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease.
    Bala S; Csak T; Kodys K; Catalano D; Ambade A; Furi I; Lowe P; Cho Y; Iracheta-Vellve A; Szabo G
    J Leukoc Biol; 2017 Aug; 102(2):487-498. PubMed ID: 28584078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity in alcoholic liver disease.
    Gao B; Seki E; Brenner DA; Friedman S; Cohen JI; Nagy L; Szabo G; Zakhari S
    Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G516-25. PubMed ID: 21252049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
    Nagata K; Suzuki H; Sakaguchi S
    J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology in alcoholic liver disease.
    Duddempudi AT
    Clin Liver Dis; 2012 Nov; 16(4):687-98. PubMed ID: 23101977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory strategies in alcoholic steatohepatitis.
    Enomoto N; Takei Y; Yamashina S; Ikejima K; Kitamura T; Sato N
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S59-61. PubMed ID: 17567468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice.
    Caracciolo V; Young J; Gonzales D; Ni Y; Flowers SJ; Summer R; Waldman SA; Kim JK; Jung DY; Noh HL; Kim T; Blackshear PJ; O'Connell D; Bauer RC; Kallen CB
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E676-E693. PubMed ID: 29509432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent insights into the role of the innate immune system in the development of alcoholic liver disease.
    Nagy LE
    Exp Biol Med (Maywood); 2003 Sep; 228(8):882-90. PubMed ID: 12968059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system.
    Li Z; Lin H; Yang S; Diehl AM
    Gastroenterology; 2002 Oct; 123(4):1304-10. PubMed ID: 12360490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat: a matter of disturbance for the immune system.
    Federico A; D'Aiuto E; Borriello F; Barra G; Gravina AG; Romano M; De Palma R
    World J Gastroenterol; 2010 Oct; 16(38):4762-72. PubMed ID: 20939104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines in alcoholic liver disease.
    An L; Wang X; Cederbaum AI
    Arch Toxicol; 2012 Sep; 86(9):1337-48. PubMed ID: 22367091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies.
    Frasinariu OE; Ceccarelli S; Alisi A; Moraru E; Nobili V
    Dig Liver Dis; 2013 Jul; 45(7):543-51. PubMed ID: 23280158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
    Mendel I; Yacov N; Shoham A; Ishai E; Breitbart E
    Dig Dis Sci; 2016 Sep; 61(9):2545-53. PubMed ID: 27074921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity.
    Nath B; Szabo G
    Semin Liver Dis; 2009 May; 29(2):166-77. PubMed ID: 19387916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory pathways in liver homeostasis and liver injury.
    Tacke F; Luedde T; Trautwein C
    Clin Rev Allergy Immunol; 2009 Feb; 36(1):4-12. PubMed ID: 18600481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
    Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
    Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice.
    Cohen JI; Roychowdhury S; McMullen MR; Stavitsky AB; Nagy LE
    Gastroenterology; 2010 Aug; 139(2):664-74, 674.e1. PubMed ID: 20416309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
    Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A
    Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
    Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.